Ginevra Botta

11 papers · 286 indexed citations

Immediate Impact

50 hit

Sub-graph 1 of 24

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges

2025 Hit

Antioxidant Metabolism Pathways in Vitamins, Polyphenols, and Selenium: Parallels and Divergences

2024 Hit

7 intermediate papers

PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma

2014

Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins

2012

and 4 more

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ginevra Botta	165	102	98	40	37	11	286
Majid Ghahremani	209 1.3×	148 1.5×	56 0.6×	12 0.3×	48 1.3×	11	324
Yi‐Ting Chuang	173 1.0×	20 0.2×	101 1.0×	25 0.6×	20 0.5×	13	331
Justin H. Gundelach	107 0.6×	24 0.2×	65 0.7×	24 0.6×	18 0.5×	13	188
Rahul Sanawar	208 1.3×	32 0.3×	73 0.7×	21 0.5×	28 0.8×	14	306
Shakchhi Joshi	147 0.9×	19 0.2×	76 0.8×	51 1.3×	16 0.4×	12	316
Rubí Viedma‐Rodríguez	195 1.2×	55 0.5×	76 0.8×	21 0.5×	30 0.8×	11	311
Rachel Ruoff	224 1.4×	47 0.5×	66 0.7×	9 0.2×	108 2.9×	15	330
Sherif S. Morgan	178 1.1×	84 0.8×	99 1.0×	61 1.5×	44 1.2×	9	329
Jason C. Hall	159 1.0×	35 0.3×	140 1.4×	29 0.7×	16 0.4×	8	329
Jinping Lu	172 1.0×	50 0.5×	76 0.8×	44 1.1×	37 1.0×	12	295

Loading papers...